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Abstract
Background: Cysteinyl residues in actin are glutathionylated, ie. form a mixed disulfide with
glutathione, even in the absence of exogenous oxidative stress. Glutathionylation inhibits actin
polymerization and reversible actin glutathionylation is a redox dependent mechanism for
regulation of the cytoskeleton structure. The molecular mechanism that mediates actin
glutathionylation in vivo is unclear.
Results: We have studied glutathionylation of α- and β-actin in vitro using an enzyme-linked
immunosorbant assay with a monoclonal anti-glutathione antibody. α- and β-actin were both
glutathionylated when incubated with reduced glutathione (GSH) combined with diamide as a thiol
oxidant. However, β-actin was also glutathionylated by both glutathione disulfide (GSSG) and GSH
in the absence of diamide whereas α-actin was poorly glutathionylated by GSH or GSSG.
Glutathionylation of β-actin by GSSG is likely to be mediated by a thiol-exchange mechanism
whereas glutathionylation by GSH requires thiol oxidation. β-actin glutathionylation by GSH was
inhibited by arsenite and dimedone suggesting that the mechanism involved formation of a cysteinyl
sulfenic acid residue in β-actin.
Conclusion: We conclude that glutathionylation of β-actin may occur via spontaneous oxidation
of a cysteinyl residue to a sulfenic acid that readily reacts with GSH to form a mixed disulfide. We
also show that the reactivity and oxidation to a reactive protein thiol intermediary differ between
different actin isoforms.
Background
Protein glutathionylation occurs by the formation of a
mixed disulfide between a protein cysteinyl residue and
glutathione [1,2]. It occurs in response to oxidative stress
and has been suggested to be a mechanism to protect
against irreversible oxidation of critical protein cysteinyl
residues. Protein glutathionylation is reversible and
reduction of the mixed glutathione-protein disulfides is
efficiently catalyzed by glutaredoxins [3,4]. Several pro-
teins have been identified by proteomic analysis as targets
of glutathionylation in response to oxidative stress [5-7].
However, there is also evidence that protein glutathio-
nylation may occur in the absence of exogenous oxidative
stress and several studies suggest that it may be an impor-
tant redox dependent signaling pathway and that glutath-
ionylation directly regulates protein functions in vivo
[1,2].
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Actin was early identified as one of the most abundant
protein that is glutathionylated in cells. Actin glutathio-
nylation was first reported to occur in human neu-
trophiles stimulated with phorbol diesters to induce
production of superoxide [8]. However, subsequent stud-
ies have shown that actin is constitutively glutathio-
nylated in cells even in the absence of oxidative stress
[9,10]. Glutathionylation efficiently inhibits actin polym-
erization and accordingly affects the cellular cytoskeleton
structure [9-11]. Growth factors, such as epidermal
growth factor, as well as interactions with the extracelllar
matrix via integrin receptors has been shown to regulate
actin polymerization by affecting the level of glutathio-
nylation [9,12]. The molecular mechanism that mediates
actin glutathionylation in vivo is unclear. Proposed mech-
anisms include oxidation of reduced glutathione (GSH)
to glutathione disulfide (GSSG), which in turn can
undergo thiol-disulfide exchange reactions with protein
thiols to form glutathionyated proteins. However, under
physiological conditions the concentration of GSH greatly
exceeds the concentration of GSSG in cells, and unless the
GSSG concentrations reach very high levels, GSSG
unlikely glutathionylate proteins based on typical redox
potentials of cysteinyl residues [13]. There is also several
lines of experimental evidence against thiol-disulfide
exchange with GSSG as the physiological mechanism
mediating actin glutathionylation [14,15]. Other pro-
posed mechanism includes formation of reactive glutath-
ione species, such as glutathione-thiyl radicals, that can
react with cysteinyl residues to form mixed disulfides.
Studies on actin glutathionylation have predominantly
been performed on cell lines of non-muscle origin. How-
ever, several isoforms of actin exists in mammalian cells
with differences in tissue distribution: α-actin is present in
muscle cells whereas β- and γ-actin are components of the
cytoskeleton in all non-muscle cells [16]. The actin iso-
forms show structural similarity with >90% identical pri-
mary structure. We have in the present paper studied
glutathionylation of skeletal muscle α-actin and non-
muscle β-actin in vitro using a highly sensitive enzyme-
linked immunosorbant assay for detection of actin glu-
tathionylation. In summary, we provide evidence that glu-
tathionylation of β-actin occurs via spontaneous
oxidation of a cysteinyl residue to a sulfenic acid that read-
ily reacts with GSH to form a mixed disulfide.
Results
A highly sensitive ELISA for detection of actin 
glutathionylation in vitro
We used a monoclonal anti-glutathione antibody to
develop an ELISA for detection of actin glutathionylation
in vitro. 96-well plates were coated with α- or β-actin and
incubated with DTT to reduce any disulfides present in the
samples. Diamide is a strong thiol-specific oxidant and
incubation with diamide and GSH has successfully been
used to glutathionylate actin in vitro [14,15]. We incu-
bated the actins with combinations of 1 mM GSH and/or
1 mM diamide (Figure 1A). Actin glutathionylation was
detected in the assay with an anti-glutathione antibody.
No signal was detected in the wells that had not been
coated with actin, independently from the incubation
with DTT, GSH, diamide or any combinations of these
reagents (data not shown). Accordingly, these reagents do
not bind to the plates and interfere with the assay. A signal
was detected when both α- and β-actin were incubated
with GSH and diamide. The signal/background ratio for
detection of the in vitro glutahionylated actin was ≈10:1.
This signal was reduced to the background level when
DTT was added to the samples. The decrease of the signal
to background level by DTT reduction shows that the glu-
tathione was bound to actin by a disulfide and not
through non-covalent interactions. The plates were coated
with different concentrations of actin (10-5–10-1 g/l) to
test the sensitivity of the assay (Figure 1B). The anti-glu-
tathione antibody was used to detect glutathionylation
after incubation with GSH and diamide as described
above. Dilution of α- and β-actin to <10-3 g/l during coat-
ing of the plates was sufficient for detection of actin glu-
tathionylation. The coating of the proteins to the plate
was performed in 50 µl/well, ie <50 ng (<1.2 pmol) actin
per well was required for detection of glutathionylated
actin in the assay. Accordingly, our data indicated that the
assay was sensitive and specific for detection of actin glu-
tathionylation in vitro.
An unexpected finding in the studies on actin glutathio-
nylation was that β-actin, but not α-actin, was glutathio-
nylated when incubated with GSH in the absence of
diamide (Figure 1A). Similar to the diamide incubated
samples, the ELISA signal decreased to background level
when DTT was added to the samples indicating that the
signal was due to the formation of a mixed disulfide
between β-actin and glutathione (data not shown).
β-actin is glutathionylated by GSH in vitro
We decided to further investigate and elucidate the mech-
anism of β-actin glutathionylation by GSH without
diamide or other thiol oxidants present. α- or β-actin were
sequentially treated as indicated in figures 2A and 2B with
DTT to reduce any disulfides, incubated with 1 mM GSH
or GSSG, and reduced again with DTT (Figure 2A and 2B).
We did not detect any glutahionylation of α-actin above
background levels when this actin isoform was incubated
with either GSSG or GSH under any of these conditions.
In contrast, β-actin was glutathionylated by both GSSG
and GSH. Similar to the previous experiments, the ELISA
signal for β-actin glutathionylation was decreased to back-
ground levels when DTT was added after glutathionyla-
tion. These findings suggested that β-actin was moreBMC Biochemistry 2007, 8:26 http://www.biomedcentral.com/1471-2091/8/26
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reactive and easily glutathionylated by GSH or GSSG com-
pared to α-actin.
The glutathionylation of β-actin by GSH was rapid and
occurred within minutes of incubation whereas α-actin
was poorly glutathionylated (Figure 3A). We decided to
quantify the amounts of α- and β-actin immobilized on
the plates to exclude that the differences in glutathionyla-
tion rate of was due to differences in amounts of the two
actin isoforms coated on the ELISA plates. A highly selec-
tive biotinylation reagent (NHS-LC-biotin) was used to
label primary amine groups of the α- and β-actin coated
on the plates and we detected the biotinylated molecules
with a streptavidin conjugate to determine the relative
amount of proteins immobilized on the plates (Figure
3B). The amount of primary amines was similar for α- and
β-actin, suggesting that the difference in glutathionylation
was not due to difference in amount of proteins immobi-
Detection of actin glutathionylation using an anti-glutathione  antibody ELISA Figure 1
Detection of actin glutathionylation using an anti-glu-
tathione antibody ELISA. (A) α- and β-actin coated on 
the plates were incubated with 1 mM GSH in the absence or 
presence of 1 mM diamide and 1 mM DTT. (B) Sensitivity of 
the assay for detection of glutathionylated actin coated on 
the plates.
Glutathionylation of α- and β-actin Figure 2
Glutathionylation of α- and β-actin. Glutathionylation of 
α- and β-actin by 1 mM GSSG (A) or 1 mM GSH (B). The 
indicated samples were incubated with (i) 1 mM DTT, after 
which 1 mM GSSG (A) or GSH (B) was added (ii) and a sec-
ond incubation with 1 mM DTT was performed (iii).BMC Biochemistry 2007, 8:26 http://www.biomedcentral.com/1471-2091/8/26
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lized on the plates. We also used NEM-biotin to label free
thiol groups to determine if there was a difference in
accessible thiols between α- and β-actin. Similar to the
labeling of the amine groups, no difference in accessible
free thiols was observed for the proteins. Accordingly,
these data suggest that the difference between glutathio-
nylation of α- and β-actin was not due to difference in
binding to the plates but rather a difference in the intrinsic
reactivity of the proteins to GSH and GSSG.
Glutathionylation of β-actin by GSH requires a thiol oxi-
dation. However, we could not exclude that the GSH used
in the experiments had undergone partial oxidation to
GSSG. If GSSG was present in the samples, one possible
mechanism for β-actin glutathionylation was direct
disulfide exchange between GSSG and actin thiols. How-
ever, we tested the concentrations of GSH and GSSG
required to induce glutathionylation of β-actin (Figure
4A). These experiments showed that a lower concentra-
tion of GSH compared to GSSG resulted in glutathionyla-
tion of the protein. We also tested the effect of adding
Grx1 to the reaction after 15 min incubation with GSH
(Figure 4B). Addition of Grx1 resulted in reversal of the
reaction and deglutathionylation of β-actin. These experi-
ments excluded the possibility that glutathionylation of β-
actin occurred by thiol-disulfide exchange with GSSG.
Identification of a cysteinyl sulfenic acid intermediary in β-
actin
Glutathionylation of actin by a mechanism independent
of thiol-disulfide exchange suggested the formation of a
reactive thiol intermediary. Oxidation of cysteinyl thiols
to sulfenic acid derivatives have been identified in pro-
teins such as the bacterial transcription factor OxyR and
the redox regulated protein tyrosine phosphatase 1B
(PTP1B) [17,18]. Cysteinyl sulfenic acids are susceptible
to a nucleophilic attack by thiols and can readily react
with GSH to form glutathionylated proteins [1]. Oxida-
tion of the active-site cysteine in PTP1B to a sulfenic acid
derivative occurs spontaneously in aerobic solution [19].
We hypothesized that a cysteinyl sulfenic acid intermedi-
ary was formed in human β-actin and that it reacted with
GSH to glutathionylate the protein. Dimedone is a nucle-
ophilic reagent that forms an adduct with sulfenic acids
but does not react with reduced thiols [20,21]. Arsenite
specifically reduces sulfenic acids to thiols but does not
reduce disulfides [18,21]. Addition of either dimedone or
arsenate to β-actin prior to addition of GSH resulted in a
marked inhibition of β-actin glutationylation (Figure 5A).
In summary, these data suggest that a cysteinyl residue in
β-actin, but not α-actin, is spontaneously oxidized to a
sulfenic acid that in turn rapidly reacts with GSH to glu-
tathionylate the protein (Figure 5B).
Discussion
Glutathionylation regulates actin polymerization and this
is an important redox dependent mechanism of modulat-
Kinetics of α- and β-actin glutathionylation Figure 3
Kinetics of α- and β-actin glutathionylation. (A) Glu-
tathionylation of α- and β-actin by GSH. The ELISA plates 
were coated with actin as described in Methods, incubated 
first with 5 mM DTT to reduce thiols and then incubated 
with 1 mM GSH at 22°C. (B) Quantification of relative 
amounts of actin immobilized on the plates (primary amine 
groups labelled with NHS-biotin) and accessible free thiols 
(thiols labelled with NEM-biotin).BMC Biochemistry 2007, 8:26 http://www.biomedcentral.com/1471-2091/8/26
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ing cytoskeleton structure. Actin glutathionylation occurs
even in the absence of exogenous oxidative stress and the
mechanism mediating actin glutathionylation in the
reducing intracellular environment is unclear as several
studies provide evidence against direct thiol-exchange
[14,15]. We have shown in the present study that β-actin
is rapidly glutathionylated in vitro by GSH and we provide
evidence that the reaction occurs via a cysteinyl sulfenic
acid residue in β-actin that in turn reacts with GSH to form
the protein-glutathione mixed disulfide. Oxidation of the
actin cysteinyl to the corresponding sulfenic acid occurs
readily without addition of an exogenous thiol oxidant,
which suggests that the intrinsic properties of the actin
cysteinyl render it highly susceptible to oxidization. Glu-
tathionylation via a reactive cysteinyl intermediary
explains how actin can be selectively glutathionylated in
the reducing intracellular environment where the major-
ity of protein thiols are reduced. It also explains how glu-
tathionylation can occur even in the presence of high
concentration of intracellular GSH as the reaction is inde-
pendent on the relative concentrations of GSH and GSSG.
Although our studies on actin glutathionylation have
been performed in vitro, we find it likely that a similar
reaction with a readily formed reactive thiol intermediary
mediates actin glutathionylation in vivo.
We observed that glutathionylation of β-actin by GSH or
GSSG was different if the protein had been treated with
DTT or not before addition of glutathione (Figure 2).
Incubation with GSSG only resulted in glutathionylation
if the protein was reduced with DTT whereas incubation
with GSH resulted in glutathionylation independent on
DTT treatment. These findings are consistent with the for-
mation of a cysteinyl sulfenic acid intermediary. DTT
untreated  β-actin has oxidized the target cystein to a
cysteinyl sulfenic acid and is only glutathionylated by
GSH. GSSG can not react with the sulfenic acid as there is
no reducing moiety in the redox reaction. DTT treatment
reduces the sulfenic acid to a thiol that can undergo thiol-
exchange with GSSG to glutathionylate the protein. How-
ever, the thiol can also oxidize again to a sulfenic acid that
in turn reacts with GSH to glutathionylate the protein.
Cysteinyl sulfenic acids have been identified in an increas-
ing number of proteins in response to oxidative stress and
Glutathionylation and deglutathionylation of β-actin Figure 4
Glutathionylation and deglutathionylation of β-actin. 
Glutathionylation of actins by different concentrations of 
GSH and GSSG (A). Deglutathionylation of β-actin catalyzed 
by Grx1 (B)
Evidence of a cysteinyl sulfenic acid intermediary in β-actin Figure 5
Evidence of a cysteinyl sulfenic acid intermediary in 
β-actin. Inhibition of β-actin glutathionylation by arsenite 
and dimedone (A). A model for glutathionylation of β-actin 
via a cysteinyl sulfenic acid intermediary (B).BMC Biochemistry 2007, 8:26 http://www.biomedcentral.com/1471-2091/8/26
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exposure to thiol oxidants [21,22]. However, there is also
evidence that cysteinyl sulfenic acids are formed in cells
during constitutive metabolism without exposure to oxi-
dative stress [21]. Oxidation of cysteinyl thiols by H2O2 is
likely the major mechanism for formation for cysteinyl
sulfenic acids under physiological conditions [21,22].
Low levels of H2O2 are produced endogenously and there
is also evidence that H2O2 may be an important signaling
molecule in cellular signal transduction pathways [23].
One example of such signaling pathway is induction of
H2O2 production by epidermal growth factor that cause
inactivation of PTP1B by reversible oxidation of an active
site thiol in the enzyme [17,24]. PTP1B cystein 215 is oxi-
dized to a sulfenic acid by H2O2 and this cysteinyl sulfenic
acid may be further irreversibly oxidized to sulfinic or sul-
fonic acids. However, rapid reaction with GSH and glu-
tathionylation of the active site cysteinyl sulfenic acid
prevents oxidation to an irreversible oxidation state
[25,26]. We hypothesize that actin glutathionylation may
occur by a mechanism similar to PTP1B glutathionylation
in response to H2O2 produced endogenously in cells. Glu-
tathionylation of proteins via a sulfenic acid intermediary
has been suggested to occur in other proteins as well and
it may be a general mechanism in cells to mediate protein
glutationylation [1,2,22,27].
Protein glutathionylation is reversible and the level of glu-
tathionylated actin is determined by both the rate of glu-
tathionylation as well as the rate of deglutathionylation.
Our data suggest that actin glutathionylation occurs non-
enzymatically via a cysteinyl intermediary whereas actin
deglutathionylation occurs by thiol-exchange with GSH
catalyzed by Grx1 (Figure 4B). The level of glutathio-
nylated β-actin is, according to our model, determined by
the Grx1 activity and the rate of formation of the cysteinyl
sulfenic acid and the non-enzymatic reaction between the
sulfenic acid and GSH. This is highlighted in the experi-
ment presented in Figure 4B where β-actin was incubated
with GSH to first glutathionylate the protein and Grx1 was
subsequently added. Addition of Grx1, without addition
of GSH or another reducing agent, resulted in rapid
reversal of the reaction and deglutathionylation the pro-
tein. This experiment supports that protein glutathionyla-
tion and deglutathionylation can occur in parallel in a
GSH containing redox buffer. This model of actin glutath-
ionylation explains how actin can become glutathio-
nylated even in the presence of high concentrations of
GSH as is present intracellularly. GSH is inefficient by
itself to reduce the glutathionylated actin but addition of
Grx1 rapidly reduces the mixed disulfide via thiol-
exchange with GSH.
α- and β-actin have >90% conserved primary structure but
the number of cysteinyl residues differ between the actin
isoforms [16]. Muscle α-actin has five cysteinyl residues
whereas non-muscle β- and γ-actin have six cysteinyl resi-
dues. The C-terminal located cystein 374, that is con-
served in all actin isoforms, has been identified as a target
for glutathionylation in α-actin [9,11]. However, a recent
study by Lassing and co-workers identified cystein 272 as
the most reactive cysteinyl residue in β-actin [28]. This
cysteinyl residue is unique to β- and γ-actin as α-actin does
not contain a cysteinyl residue in the corresponding struc-
tural location. Cystein 272 is located at the protein surface
and is easily oxidized by H2O2 [28]. We find it likely that
the presence of cystein 272 in β-actin explains that the for-
mation of a cysteinyl sulfenic acid only occurs in β-actin
and not in α-actin. Our findings suggest that redox regula-
tion of actin polymerization via reactive protein thiols
and protein glutathionylation differ between skeletal
muscle compared to other tissues where β-actin is a major
component of the cytoskeleton.
Conclusion
We provide evidence that β-actin glutathionylation may
occur by a mechanism involving the spontaneous oxida-
tion of a cysteinyl residue to a sulfenic acid. The reactive
cysteinyl sulfenic acid can readily react with GSH to form
a mixed disulfide and glutathionylate the protein. These
finding explain how β-actin may be glutathionylated in
the reducing environment of the cytosol.
Methods
Human platelet β-actin and rabbit skeletal muscle α-actin
were obtained from Cytoskeleton Inc. (Denver, CO,
USA). 96-well Maxi-Sorp ELISA plates (Nunc Inc) were
coated with 1 µg/ml α- or β-actin in pH 9.6 carbonate
buffer for 30 min at 22°C. Thiols were reduced with 5 mM
DTT in PBSET (phosphate buffered saline, pH 7.4 with 1
mM EDTA and 0.05% Tween-20) for 15 min at 37°C. The
plates were washed four times with PBST (phosphate buff-
ered saline, pH 7.4 with 0.05% Tween-20). GSH or GSSG
were added with or without diamide (Sigma) as indicated
and the samples incubated 15 min at 22°C unless other
incubation times were stated. The deglutathionylation
assay with human recombinant glutaredoxin 1 (Grx1)
(IMCO Corporation Ltd AB, Stockholm, Sweden) was per-
formed with β-actin coated and reduced on the plates as
described above. 1 mM GSH was added to the plates incu-
bated at 22°C. Grx1 (1 µM) was added in the same GSH
buffer at 15 min and incubation continued to the time-
points indicated. 5,5-dimethyl-1,3-cyclohexanedioned-
imedone (dimedone) (Sigma) or arsenite was added as
indicated. All reactions was terminated by washing the
wells four times with PBST.
Actin glutationylation was detected with a monoclonal
anti-glutathione antibody (Research Diagnostics, MA,
USA. Inc). The antibody was diluted 1:1000 in PBST sup-
plemented with 1% (w/v) fraction V bovine serum albu-BMC Biochemistry 2007, 8:26 http://www.biomedcentral.com/1471-2091/8/26
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min (Sigma) and added to the samples for 1 h incubation.
The plates were washed four times in PBST and an anti-
mouse alkaline phosphatase conjugated antibody
(Sigma) diluted 1:1000 in PBST with 1% (w/v) fraction V
bovine serum albumin was added and incubated for 1 h.
The plates were washed four times in PBST and 1 mg/ml
p-nitrophenyl-phosphate (Sigma) dissolved in 10%
diethanolamine pH 9.8 with 0.5 mM MgCl2 was added.
Absorbance at 405 nm was determined using a micro-titer
plate reader (Wallac).
Relative amounts of α- or β-actin immobilized on the
ELISA plates were determined by biotinylating primary
amine groups of the proteins. The actins were coated on
the plates and 2 µM Sulfo-NHS-LC-Biotin (Pierce Biotech-
nology Inc.) in PBST was added and incubated 15 min at
22°C. Free protein thiols were quantified after reduction
with 5 mM DTT in PBSET by biotinylation of thiol groups.
2 µM of NEM-biotin (Sigma) was added in PBST and incu-
bated as described above. The plates were washed with
PBST and the biotinylated proteins detected by 30 min
incubation with streptavidin-alkaline phosphatase
(Mabtech AB, Stockholm, Sweden) diluted 1:1000 in
PBST with 1% (w/v) fraction V bovine serum albumin.
The plates were developed with p-nitrophenyl-phosphate
as described above.
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